Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

NIB 11mg Tablet XR

Prescription Icon
Prescription Required

Marketer

Zuventus Healthcare Ltd

Salt Composition

Tofacitinib (11mg)

Overview NIB 11mg Tablet XR

XR-11 (11mg extended-release tablets) is indicated for moderate-to-severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. It alleviates joint pain, tenderness, and swelling by suppressing inflammation and slowing the progression of bone and joint deterioration. XR-11 may be administered alone or in conjunction with other medications. Tablets can be ingested with or without food, ideally at the same time daily. Dosage is individualized based on your health status and other medications. Always adhere to your physician's prescribed regimen. Discontinue use only under your doctor's direction, as abrupt cessation may exacerbate your condition. Common side effects include upper respiratory infections, headaches, diarrhea, and nasopharyngitis. Less frequent, but potentially serious, adverse events such as blood clots and gastrointestinal perforations necessitate immediate medical attention. Report any concerns regarding side effects to your doctor. Pre-treatment blood work may be required. Do not initiate treatment if you have an infection. Consult your physician before starting XR-11 if you have or have had tuberculosis, herpes zoster, hepatic or renal impairment, hepatitis B or C, or pulmonary or venous thromboembolism. XR-11 increases susceptibility to infection and may worsen existing infections; minimize contact with individuals exhibiting contagious illnesses (e.g., varicella, measles, influenza). This medication is contraindicated in patients under 18 years of age and during pregnancy or breastfeeding unless the potential benefits clearly outweigh the risks. Regular medical monitoring may be necessary.

Primary Ingredients of NIB 11mg Tablet XR

No text provided to rephrase.

Uses of NIB 11mg Tablet XR

Managing rheumatoid, psoriatic, and ankylosing spondylitis arthritis, plus ulcerative colitis.

Major Benefits of NIB 11mg Tablet XR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The NIB 11mg Tablet XR can be administered with or without food, although consistent daily timing is recommended.

Common Side effects of NIB 11mg Tablet XR:

  • Upper respiratory tract infection
  • Headache
  • Diarrhea
  • Nasopharyngitis (inflammation of the throat and nasal passages)

How to use NIB 11mg Tablet XR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The NIB 11mg Tablet XR can be administered with or without food, though consistent timing is recommended for optimal results.

How NIB 11mg Tablet XR works:

Extended-release NIB 11mg tablets are Janus kinase inhibitors that suppress Janus kinase enzyme activity. This reduces immune system responsiveness and inflammation characteristic of rheumatic conditions and ulcerative colitis.

SAFETY ADVICE

AlcoholAlcoholSAFE

There are no known adverse reactions associated with concomitant alcohol ingestion and NIB 11mg Tablet XR.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release NIB 11mg tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against potential dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release NIB 11mg tablets are likely not suitable for use while breastfeeding. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.

DrivingDrivingSAFE

Extended-release NIB 11mg tablets typically have no impact on driving capabilities.

KidneyKidneyCAUTION

Extended-release NIB 11mg tablets require careful administration in individuals with advanced kidney impairment. Dosage modification of NIB 11mg extended-release tablets might be necessary. Physician consultation is advised.

LiverLiverCAUTION

Extended-release NIB 11mg tablets require careful administration in individuals with advanced hepatic impairment. Dosage modification for NIB 11mg extended-release tablets may be necessary. Physician consultation is advised.

What if you forget to take NIB 11mg Tablet XR :

Should you forget to take a scheduled dose of your 11mg extended-release NIB tablet, administer it at your earliest convenience. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About NIB 11mg Tablet XR

LabelValue
Chemical Type Pyrrolopyrimidine Compound
Developing Habits No.
Type of Therapy Pain Relievers
Action Class JAK inhibitors

FAQs on NIB 11mg Tablet XR

Tell your doctor about any liver problems before starting NIB 11mg Tablet XR. This medication may increase liver enzymes in some individuals, so your liver function should be checked beforehand. NIB 11mg Tablet XR can be used in patients with mild to moderate liver impairment, but it's contraindicated in those with severe impairment.
Extended-release 11mg NIB tablets may increase the risk of certain cancers, such as lymphoma and skin cancer, by altering immune function. Tell your doctor if you have a history of cancer.
NIB 11mg Tablet XR treats moderate to severe rheumatoid arthritis, an inflammatory joint disease. It's used when prior treatments proved ineffective or unsuitable, or early in treatment if initial medications fail. It may be administered alone or in conjunction with other drugs, like methotrexate.
You may not feel the full benefit of NIB 11mg XR tablets for 3 to 6 months, though some improvement may be noticed within 2 to 8 weeks.
Before and during treatment with NIB 11mg Tablet XR, blood tests may be necessary to monitor for anemia, neutropenia, lymphopenia, high cholesterol, and elevated liver enzymes. These tests help assess the drug's impact and identify potential problems. Your doctor may also recommend a tuberculosis test before starting NIB 11mg Tablet XR, as the medication could exacerbate an existing infection.
NIB 11mg Tablet XR impacts the immune system, potentially lowering your infection resistance and raising the risk of serious infections, such as tuberculosis. This includes potentially life-threatening, disseminated fungal, bacterial, or viral infections, requiring hospitalization.
Tocilizumab and NIB 11mg Tablet XR shouldn't be taken together. Since NIB 11mg Tablet XR weakens the immune system, combining it with another immunosuppressant like tocilizumab significantly raises your infection risk and potential complications.
NIB 11mg Tablet XR
510
MRP 590
13% off